Delivery Order SPE2DB24D1104-SPE2DB24FXZT0
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,213.68, is for the supply of 4,568,175,168 units of the medication Aprepitant 40 mg capsules. The award does not have a set-aside designation, indicating open competition. The contract has a period of performance through May 8, 2025. AmerisourceBergen also holds a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,368.44 firm fixed price delivery order is for the supply of 40 mg Aprepitant capsules, which are a specialty pharmaceutical product used in medical treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.82 firm-fixed-price delivery order is for the supply of APREPITANT 40 MG CAPSULE UDS medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,361.04 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) for the supply of 4564857560 Aprepitant 80 mg capsules. The award has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $1,461.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. This award is not designated as a set-aside contract. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. AmerisourceBergen Drug Corp,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.80 Firm Fixed Price Delivery Order contract is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,569.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, for an...
- This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXZT0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.17 firm fixed-price delivery order is for the supply of Aprepitant 40 mg capsules, a medication used to treat nausea and vomiting associated with cancer chemotherapy. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC serves as a primary contracting vehicle for critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/27/24 |